Evolutionary Dynamics of the Lineage 2 West Nile Virus That Caused the Largest European Epidemic: Italy 2011-2018.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
03 09 2019
Historique:
received: 30 07 2019
revised: 22 08 2019
accepted: 26 08 2019
entrez: 6 9 2019
pubmed: 6 9 2019
medline: 15 9 2020
Statut: epublish

Résumé

Lineage 2 West Nile virus (WNV) caused a vast epidemic in Europe in 2018, with the highest incidence being recorded in Italy. To reconstruct the evolutionary dynamics and epidemiological history of the virus in Italy, 53 envelope gene and 26 complete genome sequences obtained from human and animal samples were characterised by means of next-generation sequencing. Phylogenetic analysis revealed two Italian strains originating between 2010 and 2012: clade A, which apparently became extinct in 2013-2014, and clade B, which was responsible for the 2018 epidemic. The mean genetic distances in clade B increased over time and with the distance between sampling locations. Bayesian birth-death and coalescent skyline plots of the clade B showed that the effective number of infections and the effective reproduction number (Re) increased between 2015 and 2018. Our data suggest that WNV-2 entered Italy in 2011 as a result of one or a few penetration events. Clade B differentiated mainly as a result of genetic drift and purifying selection, leading to the appearance of multiple locally circulating sub-clades for different times. Phylodynamic analysis showed a current expansion of the infection among reservoir birds and/or vectors.

Identifiants

pubmed: 31484295
pii: v11090814
doi: 10.3390/v11090814
pmc: PMC6784286
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Clin Microbiol Infect. 2012 Dec;18(12):E545-7
pubmed: 23020657
Bioinformatics. 2005 May 15;21(10):2531-3
pubmed: 15713735
Euro Surveill. 2016 Sep 15;21(37):
pubmed: 27684046
Sci Rep. 2018 Apr 17;8(1):6088
pubmed: 29666401
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13757-62
pubmed: 11717435
Emerg Infect Dis. 2006 Apr;12(4):618-23
pubmed: 16704810
Cell Host Microbe. 2016 Apr 13;19(4):481-92
pubmed: 27049584
BMC Genomics. 2008 Jan 07;9:5
pubmed: 18179705
Vet Microbiol. 2013 Jul 26;165(1-2):61-70
pubmed: 23570864
Euro Surveill. 2011 Oct 27;16(43):null
pubmed: 22085600
Mol Biol Evol. 2008 Jul;25(7):1253-6
pubmed: 18397919
Virology. 1999 Dec 20;265(2):218-25
pubmed: 10600594
Vet Microbiol. 2012 Aug 17;158(3-4):267-73
pubmed: 22406344
Emerg Infect Dis. 2011 Oct;17(10):1868-72
pubmed: 22000357
Emerg Infect Dis. 2005 Dec;11(12):1842-7
pubmed: 16485468
Euro Surveill. 2012 May 17;17(20):null
pubmed: 22642945
Virus Evol. 2015 May 26;1(1):vev003
pubmed: 27774277
Parasit Vectors. 2017 Oct 2;10(1):452
pubmed: 28969685
PLoS One. 2017 Jul 5;12(7):e0179679
pubmed: 28678837
Mol Biol Evol. 2012 Aug;29(8):1969-73
pubmed: 22367748
PLoS One. 2015 Oct 21;10(10):e0140915
pubmed: 26488475
Genetics. 2007 Jun;176(2):1035-47
pubmed: 17409078
Zh Mikrobiol Epidemiol Immunobiol. 2011 Mar-Apr;(2):29-37
pubmed: 21598612
Lancet. 2012 Dec 1;380(9857):1946-55
pubmed: 23200503
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):228-33
pubmed: 23248286
Zoonoses Public Health. 2010 May;57(3):211-9
pubmed: 20042066
Bioinformatics. 2005 Jan 15;21(2):260-2
pubmed: 15377507
Res Vet Sci. 2011 Oct;91(2):321-6
pubmed: 21334703
Virol J. 2009 Oct 12;6:165
pubmed: 19821990
Emerg Infect Dis. 2002 Dec;8(12):1372-8
pubmed: 12498650
Euro Surveill. 2018 Aug;23(32):
pubmed: 30107870
Virology. 2002 Jun 20;298(1):96-105
pubmed: 12093177
Virology. 2011 Aug 15;417(1):203-10
pubmed: 21723580
Mol Biol Evol. 2005 May;22(5):1185-92
pubmed: 15703244
Euro Surveill. 2009 Oct 08;14(40):null
pubmed: 19822123
Mol Biol Evol. 2010 Mar;27(3):570-80
pubmed: 19906793
Euro Surveill. 2008 Oct 09;13(41):null
pubmed: 18926106
Bioinformatics. 2000 Jul;16(7):573-82
pubmed: 11038328
PLoS Comput Biol. 2009 Sep;5(9):e1000520
pubmed: 19779555
J Mol Evol. 1992 Feb;34(2):126-9
pubmed: 1556748
Mol Biol Evol. 2012 Sep;29(9):2157-67
pubmed: 22403239

Auteurs

Carla Veo (C)

Department of Biomedical and Clinical Sciences "L.Sacco", University of Milan, 20157 Milano, Italy.
CRC-Coordinated Research Center "EpiSoMI", University of Milan, 20157 Milano, Italy.

Carla Della Ventura (C)

Department of Biomedical and Clinical Sciences "L.Sacco", University of Milan, 20157 Milano, Italy.

Ana Moreno (A)

Experimental Zooprophylactic Institute of Lombardy and Emilia-Romagna (IZSLER), 25124 Brescia, Italy.

Francesca Rovida (F)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.

Elena Percivalle (E)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.

Sabrina Canziani (S)

Experimental Zooprophylactic Institute of Lombardy and Emilia-Romagna (IZSLER), 25124 Brescia, Italy.

Debora Torri (D)

Experimental Zooprophylactic Institute of Lombardy and Emilia-Romagna (IZSLER), 25124 Brescia, Italy.

Mattia Calzolari (M)

Experimental Zooprophylactic Institute of Lombardy and Emilia-Romagna (IZSLER), 25124 Brescia, Italy.

Fausto Baldanti (F)

Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.

Massimo Galli (M)

Department of Biomedical and Clinical Sciences "L.Sacco", University of Milan, 20157 Milano, Italy.
CRC-Coordinated Research Center "EpiSoMI", University of Milan, 20157 Milano, Italy.

Gianguglielmo Zehender (G)

Department of Biomedical and Clinical Sciences "L.Sacco", University of Milan, 20157 Milano, Italy. gianguglielmo.zehender@unimi.it.
CRC-Coordinated Research Center "EpiSoMI", University of Milan, 20157 Milano, Italy. gianguglielmo.zehender@unimi.it.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH